Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Comparing different triple-drug combinations.

H Albrecht1

  • 1Division of Infectious Diseases, Emory University School of Medicine, Atlanta, USA.

AIDS Clinical Care
|October 10, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A national evaluation of the implementation of guideline recommendations towards antibiotic prophylaxis prior to percutaneous endoscopic gastrostomy and jejunostomy tube placement.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2025
Same author

Multicenter analysis of endoclot as hemostatic powder in different endoscopic settings of the upper gastrointestinal tract.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2021
Same author

Anticoagulant-related gastrointestinal bleeding: a real-life data analysis on bleeding profiles, frequency and etiology of patients receiving direct oral anticoagulants versus vitamin K antagonists.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2020
Same author

Happiness in dermatology: a holistic evaluation of the mental burden of skin diseases.

Journal of the European Academy of Dermatology and Venereology : JEADV·2019
Same author

Endoscopic full-thickness resection (EFTR) in the lower gastrointestinal tract.

Techniques in coloproctology·2019
Same author

Laparoscopic sphincter reconstruction after abdominoperineal resection: feasibility and technical aspects.

Techniques in coloproctology·2019
Same journal

Report from the 2008 joint ICAAC/IDSA meeting. Bevirimat: predictors of response.

AIDS clinical care·2009
Same journal

Report from the 2008 joint ICAAC/IDSA meeting. Maraviroc vs. efavirenz: a reanalysis of MERIT.

AIDS clinical care·2009
Same journal

Report from the 2008 joint ICAAC/IDSA meeting. More on raltegravir: resistance and mechanisms of action.

AIDS clinical care·2009
Same journal

Report from the 2008 joint ICAAC/IDSA meeting. Raltegravir vs. efavirenz in treatment-naive patients.

AIDS clinical care·2009
Same journal

A single case of cure?

AIDS clinical care·2009
Same journal

Darunavir now approved for use in treatment-naive patients.

AIDS clinical care·2009
See all related articles

Replacing protease inhibitors (PI) with abacavir maintained viral suppression and improved lipid profiles. PI-containing regimens were also more effective at reducing viral load in lymphoid tissue compared to PI-sparing options.

Area of Science:

  • Infectious Diseases
  • Virology
  • Pharmacology

Background:

  • Protease inhibitors (PI) are crucial components of combination antiretroviral therapy for HIV.
  • Understanding the impact of PI substitution and PI-containing regimens on viral load and lipid profiles is essential for optimizing treatment strategies.

Purpose of the Study:

  • To evaluate the efficacy of substituting abacavir for protease inhibitors in triple-drug regimens.
  • To compare the effectiveness of PI-containing versus PI-sparing regimens in reducing viral burden in lymphoid tissue.

Main Methods:

  • Comparative analysis of triple-drug regimens with and without protease inhibitors.
  • Assessment of plasma viral load suppression and lipid abnormalities.
  • Evaluation of viral burden reduction in lymphoid tissue.

Related Experiment Videos

Main Results:

  • Replacing protease inhibitors with abacavir in a triple-drug regimen led to sustained plasma viral-load suppression.
  • Abacavir-containing regimens demonstrated improvements in lipid abnormalities.
  • PI-containing triple-drug combinations showed a greater likelihood of reducing viral burden in lymphoid tissue compared to PI-sparing regimens.

Conclusions:

  • Abacavir is a viable alternative to protease inhibitors for maintaining viral suppression and improving lipid profiles.
  • Protease inhibitor-containing regimens may offer advantages in reducing viral reservoirs within lymphoid tissues.